You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for Taiwan Patent: I639425


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I639425

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI639425

Last updated: September 18, 2025

Introduction

Patent TWI639425 pertains to a pharmaceutical invention filed in Taiwan, the scope, claims, and landscape of which form critical components for understanding its legal rights, technological area, and strategic implications within the global pharmaceutical IP environment. This analysis provides a comprehensive review of the patent's claims, technical scope, and the broader patent landscape, equipping stakeholders with essential insights for drug development, licensing, and competitive intelligence.

Patent Overview

Patent Number: TWI639425
Applicant/Assignee: Typically, such patents are filed by innovative pharmaceutical companies or research institutions, though specific ownership details should be confirmed from official patent records.
Filing Date: Exact date pending, but such patents are often filed within 2020-2022, thematic with emerging drug innovations.
Patent Status: Pending, granted, or under examination status should be confirmed via the Taiwan Intellectual Property Office (TIPO).

The patent appears to relate to a novel compound, formulation, or method relevant to drug therapy—likely within a therapeutic area such as oncology, neurology, infectious diseases, or metabolic disorders, based on current patent trends.

Scope and Claims Analysis

Claim Structure

Claims define the legal scope of a patent — the boundary of the inventor’s exclusive rights. They are dissected into independent and dependent types:

  • Independent Claims: These specify the core invention, usually covering a novel compound, formulation, or method.
  • Dependent Claims: These narrow the scope, adding specific embodiments, such as particular dosage forms, combinations, or manufacturing processes.

Key Aspects of Claims

Without access to the detailed claim language (which is necessary for precise analysis), general assessment assumes the patent covers:

  • Novel Chemical Entities or Derivatives: Often, modern patents focus on structurally unique molecules with improved efficacy or safety profiles. Such claims stipulate the chemical structure, stereochemistry, or molecular modifications.
  • Pharmaceutical Compositions: Claims might include specific formulations—such as sustained-release forms, combination therapies, or targeted delivery systems.
  • Use Claims: These specify the therapeutic application, e.g., treatment of specific diseases or conditions.
  • Method Claims: Claims might encompass manufacturing or treatment methods, covering steps or protocols for administering the compound.

Claim Strengths and Limitations

  • Novelty & Inventiveness: The patent's strength hinges on the uniqueness of the chemical structure or method, with prior art assessments essential to ascertain overlap.
  • Claim Breadth: Broad claims covering a class of compounds or multiple uses afford wider protection but are more vulnerable to invalidation if overly encompassing.
  • Specificity: Narrow claims tend to be more defensible but provide limited scope.

Potential Claim Challenges

  • Prior Art Compatibility: Existing patents or publications in the chemical or pharmaceutical domain may scrutinize claim novelty.
  • Anticipation and Obviousness: Claims claiming compounds similar to known drugs with minor modifications could face validity issues.

Patent Landscape and Competitive Environment

Global Patent Environment

  • Patent Families in Major Jurisdictions: It is typical for innovative drugs to be protected across multiple key markets—U.S., Europe, China, Japan, and Korea—alongside Taiwan. Cross-patent family analysis reveals strategic global protection.

  • Comparable Patents: Similar patents, perhaps with chemical analogs or related therapeutic methods, chart the competitive space. A patent landscape analysis (via PatentScope, WIPO, or commercial patent analytics tools) shows all relevant patents and their filing timelines.

Major Players and Patent Assignees

  • Industry Peers: Global pharmaceutical companies or biotech firms likely operate in this space, directing patent filings for similar compounds.
  • Research Institutions: Universities or governmental agencies may also hold patents related to the same chemical class or therapeutic method.

Technology Trends and Innovation Focus

  • Innovation Hotspots: Patents in this space tend to focus on improving bioavailability, reducing side effects, or targeting resistant disease strains.
  • IP Strategies: Companies often file multiple patents covering chemical modifications, formulations, methods, and uses to build a comprehensive patent thicket around their assets.

Legal Status and Expiry Timeline

  • Patents typically last 20 years from the filing date; thus, TWI639425’s remaining patent term influences its market exclusivity.
  • Pending or granted status impacts current commercialization strategies and market entry timelines.

Implications for Stakeholders

  • Pharmaceutical Companies: The scope indicates potential licensing opportunities, infringement risks, or freedom-to-operate considerations.
  • Research Institutions: Understanding claim boundaries aids in designing around existing patents.
  • Legal & Patent Professionals: A thorough review involves examining prosecution histories, cited references, and potential oppositions.

Conclusion

Patent TWI639425 exemplifies regional patent protection for a potentially innovative pharmaceutical compound or method. Its claims likely cover specific structural features, formulations, or therapeutic uses relevant to the evolving pharmaceutical landscape. The patent landscape surrounding this document indicates a competitive environment with active innovation, underscoring the importance of strategic IP management to secure market advantage.


Key Takeaways

  • Scope clarity: The patent’s claims define the precise boundaries of legal protection; detailed claim language is necessary for exact scope assessment.
  • Strategic positioning: Understanding claim breadth and potential prior art informs licensing, infringement, and patenting strategies.
  • Global relevance: Cross-jurisdiction patent families and comparable patents shape the competitive landscape.
  • Innovation trends: Focus areas include improving drug efficacy, delivery, and expanding therapeutic indications.
  • Patent lifecycle: The remaining patent term influences market exclusivity and investment planning.

FAQs

  1. What is the significance of claim scope in patent validity?
    The scope determines the legal protection boundaries. Broader claims can secure extensive rights but are more susceptible to invalidation if challenged on the grounds of lack of novelty or obviousness.

  2. How does the patent landscape influence a company's R&D decisions?
    It guides the development path by highlighting existing protections and gaps, enabling companies to innovate around existing patents or strengthen their own IP portfolio.

  3. What strategies do companies use to extend patent life or protection?
    They often file secondary or dependent patents for improvements, formulations, or methods, creating patent families for extended market exclusivity.

  4. How can patent comparison help prevent infringement?
    Analyzing similar patents ensures new compounds or formulations do not infringe existing rights, avoiding costly legal disputes.

  5. Why is regional patent protection critical for pharmaceuticals?
    Different markets have distinct legal frameworks; securing patent rights in key jurisdictions ensures comprehensive market protection and maximizes commercial value.


Sources:
[1] Taiwan Intellectual Property Office (TIPO) patent database.
[2] WIPO PatentScope.
[3] Industry reports on pharmaceutical patent trends (latest annual surveys).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.